EN DE

The Clorox Company (CLX) Fair Value & Analysis

Consumer Defensive · US · Market cap $11.9B

TC The Clorox Company logo The Clorox Company CLX · US
Price$105.60
Fair Value$102.23
Upside-3.2%
Quality68/100
Watch The Clorox Company for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Solidly profitable · 11.2% net margin
High debt · generates free cash flow
5.12% dividend yield
Mixed vs. peers (8/15)
Wide moat 71/100
Evidence: High Range $61.88 – $147.48 Share as image

Fair value as of: Jul 17, 2026

From 25 valuation models · updated 21 days ago

Fair value updated Jul 17, 2026, revised from $101.33 to $102.23 (+0.9%) since Jul 15, 2026. Share price +8.4% over the past month.

A solid business, currently priced close to our fair value.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • A fairly wide model range ($61.88 to $147.48) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$159.79 $86.12 Fair Value $102.23 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 17, 2026.

How to read this chart

60‑month range $86.12 – $159.79 · fair‑value band $61.88 – $147.48 · the $105.60 price screens above the $102.23 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 17, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

The Clorox Company (CLX) currently trades at $105.60, while our model-based Fair Value estimate is $102.23, implying the stock looks roughly 3.2% fairly valued today. We read business quality at 68/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, The Clorox Company generated revenue of $6.8B at a net margin of 11.2%. Revenue grew 0.1% year over year. It earns a return on equity of 54.6%. Net debt stands at $2.7B. Fundamentals as of Jul 17, 2026

Our scenario range runs from $61.88 (bear case) to $147.48 (bull case); at $105.60, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 17% below its 52-week high and 25% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -26% fair-value upside, at -3%, CLX screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Growth DCF $48.89 $74.65 $109.36 80
Residual Income $14.78 $18.38 $115.61 76
Rev-Margin DCF $57.37 $99.34 $143.19 74
All 25 models by family
DCF Models
FCF DCF $46.74 $74.04 $112.24 38
Owner Earnings $50.90 $79.92 $120.53 31
5Y Revenue Exit $57.37 $98.68 $149.25 39
5Y EBITDA Exit $67.11 $115.75 $169.51 41
5Y P/E Exit $60.45 $104.07 $146.88 38
10Y Revenue Exit $50.25 $86.20 $129.96 36
10Y EBITDA Exit $58.81 $97.66 $144.53 37
10Y P/E Exit $54.67 $89.82 $128.25 35
Earnings-Based
Graham-Dodd $45.55 $97.20 $123.36 54
PEG = 1.0 $14.86 $21.23 $27.60 46
EPV $53.53 $65.65 $76.25 59
Dividend Discount
Gordon GGM $45.71 $70.07 $96.37 70
DDM Multi-Stage $45.71 $65.61 $88.21 61
Multiples
P/E Multiple $100.48 $133.97 $167.46 63
P/S Multiple $85.41 $113.88 $142.34 58
P/B Multiple $8.97 $11.96 $14.95 55
EV/EBIT $112.24 $156.04 $199.84 53
EV/EBITDA $93.40 $130.92 $168.44 54
EV/Revenue $69.41 $107.38 $145.34 43
Asset-Based
NCAV (Graham) $1.99 $2.67 $3.99 50
Growth DCF
Growth DCF $48.89 $74.65 $109.36 80
Rev-Margin DCF $57.37 $99.34 $143.19 74
Economic Profit
Residual Income $14.78 $18.38 $115.61 76
ROIC Compounder $55.72 $70.99 $86.36 72
Growth Earnings
Growth-Adj P/E $74.27 $106.10 $137.92 68

Widest divergence: Multiples ($113.88) versus Asset-Based ($2.67). Highest evidence: Growth DCF (80).

Key figures & financial health

Revenue (TTM) $6.8B
Revenue growth (YoY) +0.1%
Net margin 11.2%
Return on equity 54.6%
Free cash flow $761M FY2025
P/E ratio 16.1
More key figures
Operating margin 17.0%
EPS (TTM) $6.15
Dividend yield 5.1%
EPS growth (YoY) +2.7%
Net debt $2.7B FY2025

Figures from reported company fundamentals · as of Jul 17, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 68/100

Of which business quality 70 · Market factors (momentum, volatility) 51

Profitability 87
Margins and returns on capital today
Quality Growth 72
Are margins and returns improving?
Cashflow 56
Earnings quality: real cash, not paper profit
Fin. Strength 39
Balance sheet, leverage, solvency risk
Investment 98
Disciplined investing over empire-building
Low Volatility 81
Calm price path (market factor)
Momentum 40
Price trend over the last 3–12 months (market factor)
52W Momentum 36
Distance to the 52-week high (market factor)
Net Issuance 83
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates through four segments: Health and Wellness, Household, Lifestyle, and International.

Full company description

The Clorox Company manufactures and markets consumer and professional products worldwide. The company operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers home care cleaning and disinfecting products, bleach, clog removers, and laundry additives under the Clorox, Clorox2, Pine-Sol, Scentiva, Tilex, Liquid-Plumr, Poett, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; water-filtration products under the Brita brand; and natural personal care products under the Burt's Bees brand in the United States. The International segment provides laundry additives, home care products, bags and wraps, cat litter products, water-filtration systems, professional cleaning and disinfecting products, natural personal care products, food, grilling products, and digestive health products internationally primarily under the Clorox, Glad, Poett, Brita, Burt's Bees, Pine-Sol, Ever Clean, Clorinda, Chux and Fresh Step Brands. It also offers vitamins, minerals, and supplement products under the Natural Vitality, RenewLife, NeoCell, and Rainbow Light brands. The company sells its products through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet, and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force. The company was founded in 1913 and is headquartered in Oakland, California.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

The Clorox Company reported revenue of $7.1B in FY2025 versus $7.3B in FY2021, a compound −0.8%/yr. Reported net income was $810M in FY2025, compounding +3.3%/yr from FY2021.

Growth Quality 40/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2025)
$7.1B
Latest YoY
+0.2%
Avg. growth/yr (3Y)
+0.0%
Avg. growth/yr (5Y)
+1.1%
Avg. growth/yr (39Y)
+4.9%
Revenue −0.8%/yr
FY21 $7.3B
FY22 $7.1B
FY23 $7.4B
FY24 $7.1B
FY25 $7.1B
Net income +3.3%/yr
FY21 $710M
FY22 $462M
FY23 $149M
FY24 $280M
FY25 $810M

Watch CLX: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "The Clorox Company Fair Value". https://www.fairvalue-calculator.com/stock/CLX

Recent news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.

Peer Group

Household & Personal Products · 244 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 68 · Top 25%
Fair Value upside −3% · Above median
Return on equity (TTM) 55% · Top 25%
Return on assets 11% · Top 25%
Net margin (TTM) 11% · Top 25%
Operating margin (TTM) 17% · Top 25%
Revenue growth 0% · Below median
Dividend yield (TTM) 5.1% · Top 25%
Debt / equity 5.15× · Higher than 75% of peers

Valuation Multiples vs Household & Personal Products median · lower = cheaper

P/E (TTM) 16.1× · Cheaper than median
P/B 24.76× · Pricier than 75% of peers
P/S (TTM) 1.77× · Pricier than median
P/FCF 15.7× · Pricier than 75% of peers
EV/EBITDA 11.2× · Pricier than median
PEG 2.23× · Pricier than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 29 · sector 29
FUTURE 1 · sector 4
PAST 100 · sector 27
HEALTH 0 · sector 98
DIVIDEND 100 · sector 50

Insider activity: 42/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).

Stock Price Fair Value vs Fair Value
The Procter & Gamble Company PG $146.80 $108.16 -26%
Unilever PLC ULN 1,080 MXN 1,273 MXN +18%
Hindustan Unilever Limited HINDUNILVR ₹2,144 ₹1,000 -53%
Essity AB ESSITYA kr 279.00 kr 250.02 -10%
Godrej Consumer Products Limited GODREJCP ₹1,088 ₹367.64 -66%
Marico Limited MARICO ₹846.75 ₹233.05 -72%
APR Co 278470 375,000 KRW 151,222 KRW -60%
Dabur India Limited DABUR ₹429.45 ₹181.60 -58%
Kimberly-Clark de México, S. A. B. de C. V., KIMBERA 38.07 MXN 50.09 MXN +32%
PT Unilever Indonesia Tbk UNVR 1,730 IDR 1,934 IDR +12%

Compare The Clorox Company with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is The Clorox Company (CLX) overvalued or undervalued?
As of Jul 17, 2026, our model estimates a fair value of $102.23 versus a price of $105.60, about −3% (fairly valued).
What is the fair value of CLX?
Our model-based fair value for The Clorox Company is $102.23 (as of Jul 17, 2026), built from audited fundamentals. The current price is $105.60.
What is the quality score of CLX?
The Clorox Company has a Quality Score of 68/100. It combines two groups: business quality (profitability, growth, cash flow, balance-sheet strength) and market factors (price momentum, distance to the 52-week high, volatility). Both subtotals are shown separately in the detail view.
What is the revenue of The Clorox Company (CLX)?
The Clorox Company reported trailing-twelve-month revenue of about $6.8B (latest available figure, as of Jul 17, 2026).
What is the net profit margin of CLX?
The net profit margin of The Clorox Company is about 11.2%, meaning it keeps roughly 11.2% of revenue as net income. Based on the latest reported figures.
Does The Clorox Company pay a dividend?
The Clorox Company currently shows a dividend yield of about 5.60% relative to its recent price (as of Jul 17, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track The Clorox Company and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.